

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | response to peptidoglycan (GO:0032494) | 9.42955794 |
| 2 | * leukocyte aggregation (GO:0070486) | 9.24635712 |
| 3 | * leukocyte migration involved in inflammatory response (GO:0002523) | 9.16501114 |
| 4 | killing of cells of other organism (GO:0031640) | 8.99805404 |
| 5 | disruption of cells of other organism (GO:0044364) | 8.99805404 |
| 6 | * defense response to fungus (GO:0050832) | 8.17286186 |
| 7 | * response to fungus (GO:0009620) | 6.99191232 |
| 8 | respiratory burst (GO:0045730) | 6.95784913 |
| 9 | neutrophil mediated immunity (GO:0002446) | 6.73525402 |
| 10 | detection of bacterium (GO:0016045) | 6.67383696 |
| 11 | neutrophil activation involved in immune response (GO:0002283) | 6.61898860 |
| 12 | detection of other organism (GO:0098543) | 6.14769498 |
| 13 | * sequestering of metal ion (GO:0051238) | 6.00977459 |
| 14 | innate immune response in mucosa (GO:0002227) | 5.91068317 |
| 15 | antibacterial humoral response (GO:0019731) | 5.80474954 |
| 16 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.71591830 |
| 17 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.71591830 |
| 18 | modulation by symbiont of host immune response (GO:0052553) | 5.71591830 |
| 19 | positive regulation by symbiont of host defense response (GO:0052509) | 5.71591830 |
| 20 | modulation by symbiont of host defense response (GO:0052031) | 5.71591830 |
| 21 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.71591830 |
| 22 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 5.69399132 |
| 23 | regulation of growth of symbiont in host (GO:0044126) | 5.69399132 |
| 24 | negative regulation of growth of symbiont in host (GO:0044130) | 5.69399132 |
| 25 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 5.69399132 |
| 26 | phagosome maturation (GO:0090382) | 5.65420195 |
| 27 | hydrogen peroxide biosynthetic process (GO:0050665) | 5.60441967 |
| 28 | antimicrobial humoral response (GO:0019730) | 5.52802380 |
| 29 | cellular extravasation (GO:0045123) | 5.51230805 |
| 30 | reactive oxygen species biosynthetic process (GO:1903409) | 5.43354358 |
| 31 | superoxide anion generation (GO:0042554) | 5.41529036 |
| 32 | mucosal immune response (GO:0002385) | 5.40002329 |
| 33 | production of molecular mediator involved in inflammatory response (GO:0002532) | 5.38413043 |
| 34 | neutrophil activation (GO:0042119) | 5.38062276 |
| 35 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.36563263 |
| 36 | organ or tissue specific immune response (GO:0002251) | 5.11250389 |
| 37 | myeloid leukocyte mediated immunity (GO:0002444) | 5.08630771 |
| 38 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 5.04299652 |
| 39 | macrophage activation involved in immune response (GO:0002281) | 4.92977324 |
| 40 | cell killing (GO:0001906) | 4.92827182 |
| 41 | macrophage differentiation (GO:0030225) | 4.82593398 |
| 42 | granulocyte activation (GO:0036230) | 4.82394247 |
| 43 | regulation of leukocyte degranulation (GO:0043300) | 4.77705563 |
| 44 | leukotriene biosynthetic process (GO:0019370) | 4.71373943 |
| 45 | pentose-phosphate shunt (GO:0006098) | 4.67283593 |
| 46 | negative regulation of cell killing (GO:0031342) | 4.64509060 |
| 47 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.64509060 |
| 48 | detection of molecule of bacterial origin (GO:0032490) | 4.60069829 |
| 49 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.59074381 |
| 50 | leukotriene metabolic process (GO:0006691) | 4.58138517 |
| 51 | defense response to Gram-positive bacterium (GO:0050830) | 4.45137441 |
| 52 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.40831253 |
| 53 | negative regulation of phagocytosis (GO:0050765) | 4.36438377 |
| 54 | positive regulation of mast cell activation (GO:0033005) | 4.33943771 |
| 55 | regulation of regulated secretory pathway (GO:1903305) | 4.33864150 |
| 56 | negative regulation of interleukin-12 production (GO:0032695) | 4.33167649 |
| 57 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 4.26794107 |
| 58 | NADPH regeneration (GO:0006740) | 4.25148520 |
| 59 | * neutrophil chemotaxis (GO:0030593) | 4.23864997 |
| 60 | immunoglobulin mediated immune response (GO:0016064) | 4.22764673 |
| 61 | * chronic inflammatory response (GO:0002544) | 4.22107072 |
| 62 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.15128167 |
| 63 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 4.13548662 |
| 64 | positive regulation of mast cell degranulation (GO:0043306) | 4.13548662 |
| 65 | * neutrophil migration (GO:1990266) | 4.12235164 |
| 66 | microglial cell activation (GO:0001774) | 4.09848344 |
| 67 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.05004231 |
| 68 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.97922874 |
| 69 | regulation of mast cell degranulation (GO:0043304) | 3.96900409 |
| 70 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.94350043 |
| 71 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.90564165 |
| 72 | myeloid cell activation involved in immune response (GO:0002275) | 3.90449082 |
| 73 | macrophage activation (GO:0042116) | 3.86218299 |
| 74 | regulation of mast cell activation (GO:0033003) | 3.84328527 |
| 75 | regulation of gamma-delta T cell activation (GO:0046643) | 3.81775327 |
| 76 | leukocyte mediated cytotoxicity (GO:0001909) | 3.79109393 |
| 77 | cellular response to interleukin-6 (GO:0071354) | 3.78357478 |
| 78 | interaction with symbiont (GO:0051702) | 3.76461403 |
| 79 | modification by host of symbiont morphology or physiology (GO:0051851) | 3.75470957 |
| 80 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.74490610 |
| 81 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.69741448 |
| 82 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.69054320 |
| 83 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.66976639 |
| 84 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.64646105 |
| 85 | * granulocyte migration (GO:0097530) | 3.60401856 |
| 86 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.58458422 |
| 87 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.54705558 |
| 88 | response to host immune response (GO:0052572) | 3.54688613 |
| 89 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.54688613 |
| 90 | mast cell activation (GO:0045576) | 3.54644444 |
| 91 | * granulocyte chemotaxis (GO:0071621) | 3.53875456 |
| 92 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.46492051 |
| 93 | negative regulation of T cell mediated immunity (GO:0002710) | 3.46310045 |
| 94 | positive regulation of lamellipodium assembly (GO:0010592) | 3.44694722 |
| 95 | cellular response to zinc ion (GO:0071294) | 3.43118521 |
| 96 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.42653154 |
| 97 | response to muramyl dipeptide (GO:0032495) | 3.39939845 |
| 98 | * defense response to bacterium (GO:0042742) | 3.38679244 |
| 99 | detection of external biotic stimulus (GO:0098581) | 3.33944997 |
| 100 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.33043257 |
| 101 | regulation of natural killer cell differentiation (GO:0032823) | 3.32600072 |
| 102 | negative regulation of interleukin-6 production (GO:0032715) | 3.31479441 |
| 103 | B cell mediated immunity (GO:0019724) | 3.29041667 |
| 104 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.27340852 |
| 105 | response to host (GO:0075136) | 3.27340852 |
| 106 | response to host defenses (GO:0052200) | 3.27340852 |
| 107 | positive regulation of leukocyte degranulation (GO:0043302) | 3.24920412 |
| 108 | protein localization to kinetochore (GO:0034501) | 3.24857309 |
| 109 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.24825817 |
| 110 | defense response to Gram-negative bacterium (GO:0050829) | 3.23806008 |
| 111 | * leukocyte cell-cell adhesion (GO:0007159) | 3.22735257 |
| 112 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.22651655 |
| 113 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.14730016 |
| 114 | B cell receptor signaling pathway (GO:0050853) | 3.14212397 |
| 115 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.13814629 |
| 116 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.13814629 |
| 117 | actin nucleation (GO:0045010) | 3.10984889 |
| 118 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.10779286 |
| 119 | myeloid leukocyte activation (GO:0002274) | 3.09880917 |
| 120 | defense response to protozoan (GO:0042832) | 3.09524484 |
| 121 | glucose catabolic process (GO:0006007) | 3.08285446 |
| 122 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.08238182 |
| 123 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.02765827 |
| 124 | response to interleukin-6 (GO:0070741) | 3.02551759 |
| 125 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.02517526 |
| 126 | * response to bacterium (GO:0009617) | 3.02460729 |
| 127 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.02438530 |
| 128 | response to interleukin-15 (GO:0070672) | 3.01938218 |
| 129 | lipoxygenase pathway (GO:0019372) | 3.01739258 |
| 130 | germinal center formation (GO:0002467) | 3.01508794 |
| 131 | leukocyte degranulation (GO:0043299) | 3.01498039 |
| 132 | type I interferon signaling pathway (GO:0060337) | 3.01117732 |
| 133 | cellular response to type I interferon (GO:0071357) | 3.01117732 |
| 134 | positive regulation of regulated secretory pathway (GO:1903307) | 3.00704513 |
| 135 | response to type I interferon (GO:0034340) | 2.97348620 |
| 136 | regulation of tolerance induction (GO:0002643) | 2.96647966 |
| 137 | positive regulation of B cell differentiation (GO:0045579) | 2.95067108 |
| 138 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.94466276 |
| 139 | negative regulation of innate immune response (GO:0045824) | 2.94188176 |
| 140 | adaptation of signaling pathway (GO:0023058) | 2.91955583 |
| 141 | regulation of phagocytosis (GO:0050764) | 2.91285544 |
| 142 | regulation of B cell differentiation (GO:0045577) | 2.90941044 |
| 143 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.90683235 |
| 144 | protein localization to chromosome, centromeric region (GO:0071459) | 2.84338266 |
| 145 | hepatocyte differentiation (GO:0070365) | 2.80449422 |
| 146 | positive regulation of osteoblast proliferation (GO:0033690) | 2.74718816 |
| 147 | detection of biotic stimulus (GO:0009595) | 2.71763770 |
| 148 | NADP metabolic process (GO:0006739) | 2.68733381 |
| 149 | pentose metabolic process (GO:0019321) | 2.68551238 |
| 150 | positive regulation of lamellipodium organization (GO:1902745) | 2.68328017 |
| 151 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.67832798 |
| 152 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.65275803 |
| 153 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.64538975 |
| 154 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 11.8954711 |
| 155 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 11.8954711 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.46520354 |
| 2 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 5.98891161 |
| 3 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 4.79337604 |
| 4 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 4.47785437 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.03725141 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.67953456 |
| 7 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.40003385 |
| 8 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 3.35240380 |
| 9 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.30630552 |
| 10 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.20564171 |
| 11 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.18517649 |
| 12 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.89224785 |
| 13 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.88380885 |
| 14 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.86689680 |
| 15 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.84799845 |
| 16 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.76879843 |
| 17 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.56734652 |
| 18 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 2.51050142 |
| 19 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.50181202 |
| 20 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.44158899 |
| 21 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.41003894 |
| 22 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.30709990 |
| 23 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.25114782 |
| 24 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.17431129 |
| 25 | SPI1_23127762_ChIP-Seq_K562_Human | 2.07644816 |
| 26 | MAF_26560356_Chip-Seq_TH1_Human | 2.06116528 |
| 27 | UTX_26944678_Chip-Seq_JUKART_Human | 2.06032441 |
| 28 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.05364385 |
| 29 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.03996940 |
| 30 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.95189475 |
| 31 | MYB_26560356_Chip-Seq_TH2_Human | 1.91268976 |
| 32 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.87694761 |
| 33 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.87212878 |
| 34 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.85080941 |
| 35 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.82785443 |
| 36 | MYC_22102868_ChIP-Seq_BL_Human | 1.81683979 |
| 37 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.81283489 |
| 38 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.79501771 |
| 39 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.76320091 |
| 40 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.73308179 |
| 41 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.70589844 |
| 42 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.68636878 |
| 43 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.67436038 |
| 44 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.62921165 |
| 45 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.59038409 |
| 46 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.57839512 |
| 47 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.54889641 |
| 48 | MYB_26560356_Chip-Seq_TH1_Human | 1.54543320 |
| 49 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.52069963 |
| 50 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.48391673 |
| 51 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.47438254 |
| 52 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.45503915 |
| 53 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.45460435 |
| 54 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.44547078 |
| 55 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.43638396 |
| 56 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.38755620 |
| 57 | GATA1_19941826_ChIP-Seq_K562_Human | 1.38463633 |
| 58 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.38213317 |
| 59 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36133704 |
| 60 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.35409089 |
| 61 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.33207982 |
| 62 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.32910636 |
| 63 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.32391763 |
| 64 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.30603040 |
| 65 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.30216003 |
| 66 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.29569476 |
| 67 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.27028186 |
| 68 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.26669776 |
| 69 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.26639635 |
| 70 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.26313811 |
| 71 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.26283267 |
| 72 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.25982338 |
| 73 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.25179625 |
| 74 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.24511430 |
| 75 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21133845 |
| 76 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.20223681 |
| 77 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.19757301 |
| 78 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19009303 |
| 79 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.18325828 |
| 80 | GATA2_19941826_ChIP-Seq_K562_Human | 1.15360462 |
| 81 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.14489893 |
| 82 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.13362311 |
| 83 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.12716243 |
| 84 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.11121793 |
| 85 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.10942681 |
| 86 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.07967158 |
| 87 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.07250794 |
| 88 | GATA1_22025678_ChIP-Seq_K562_Human | 1.07246024 |
| 89 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.06734470 |
| 90 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06403968 |
| 91 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.05632439 |
| 92 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.05543018 |
| 93 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.05185220 |
| 94 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.04992899 |
| 95 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.03578056 |
| 96 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.01632234 |
| 97 | GATA3_26560356_Chip-Seq_TH2_Human | 1.01515642 |
| 98 | MAF_26560356_Chip-Seq_TH2_Human | 1.01007586 |
| 99 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.99982369 |
| 100 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.98225523 |
| 101 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.96414848 |
| 102 | * BCL6_27268052_Chip-Seq_Bcells_Human | 0.95742647 |
| 103 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.94855779 |
| 104 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.93683560 |
| 105 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.93570171 |
| 106 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.92166493 |
| 107 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.91321819 |
| 108 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90870143 |
| 109 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89899915 |
| 110 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.89212183 |
| 111 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.87735790 |
| 112 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.85181972 |
| 113 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.83151528 |
| 114 | * RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.81211752 |
| 115 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.80299373 |
| 116 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.79462426 |
| 117 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.76728124 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 6.55748964 |
| 2 | MP0003436_decreased_susceptibility_to | 5.62742112 |
| 3 | MP0009785_altered_susceptibility_to | 4.45599183 |
| 4 | MP0003183_abnormal_peptide_metabolism | 4.16427552 |
| 5 | MP0002419_abnormal_innate_immunity | 3.59860478 |
| 6 | MP0001533_abnormal_skeleton_physiology | 2.92206506 |
| 7 | MP0009278_abnormal_bone_marrow | 2.87266040 |
| 8 | MP0005025_abnormal_response_to | 2.76930789 |
| 9 | MP0003656_abnormal_erythrocyte_physiolo | 2.74217702 |
| 10 | MP0006082_CNS_inflammation | 2.57773396 |
| 11 | MP0005464_abnormal_platelet_physiology | 2.38247114 |
| 12 | MP0008260_abnormal_autophagy | 2.36586123 |
| 13 | MP0001851_eye_inflammation | 2.30990538 |
| 14 | MP0005000_abnormal_immune_tolerance | 2.24914950 |
| 15 | MP0000465_gastrointestinal_hemorrhage | 2.14402649 |
| 16 | MP0002405_respiratory_system_inflammati | 2.13294110 |
| 17 | MP0000343_altered_response_to | 2.10713932 |
| 18 | MP0002420_abnormal_adaptive_immunity | 2.10425240 |
| 19 | MP0001819_abnormal_immune_cell | 2.08359253 |
| 20 | MP0003724_increased_susceptibility_to | 2.04584094 |
| 21 | MP0001835_abnormal_antigen_presentation | 1.95087678 |
| 22 | MP0002452_abnormal_antigen_presenting | 1.93113809 |
| 23 | MP0002148_abnormal_hypersensitivity_rea | 1.89173957 |
| 24 | MP0005397_hematopoietic_system_phenotyp | 1.84590266 |
| 25 | MP0001545_abnormal_hematopoietic_system | 1.84590266 |
| 26 | MP0001845_abnormal_inflammatory_respons | 1.83838310 |
| 27 | MP0000685_abnormal_immune_system | 1.81789350 |
| 28 | MP0001800_abnormal_humoral_immune | 1.79346460 |
| 29 | MP0003693_abnormal_embryo_hatching | 1.78342540 |
| 30 | MP0000858_altered_metastatic_potential | 1.78072666 |
| 31 | MP0001853_heart_inflammation | 1.77461856 |
| 32 | MP0003566_abnormal_cell_adhesion | 1.76044903 |
| 33 | MP0002723_abnormal_immune_serum | 1.72758759 |
| 34 | MP0003300_gastrointestinal_ulcer | 1.72307200 |
| 35 | MP0002132_abnormal_respiratory_system | 1.72008635 |
| 36 | MP0003763_abnormal_thymus_physiology | 1.69198973 |
| 37 | MP0004808_abnormal_hematopoietic_stem | 1.65515031 |
| 38 | MP0002398_abnormal_bone_marrow | 1.61183546 |
| 39 | MP0003172_abnormal_lysosome_physiology | 1.56590812 |
| 40 | MP0003075_altered_response_to | 1.53822738 |
| 41 | MP0001790_abnormal_immune_system | 1.52018646 |
| 42 | MP0005387_immune_system_phenotype | 1.52018646 |
| 43 | MP0000716_abnormal_immune_system | 1.50887688 |
| 44 | MP0004381_abnormal_hair_follicle | 1.48783633 |
| 45 | MP0000569_abnormal_digit_pigmentation | 1.47064367 |
| 46 | MP0004883_abnormal_blood_vessel | 1.41077781 |
| 47 | MP0002396_abnormal_hematopoietic_system | 1.39465986 |
| 48 | MP0005023_abnormal_wound_healing | 1.38789436 |
| 49 | MP0009333_abnormal_splenocyte_physiolog | 1.38623983 |
| 50 | MP0002837_dystrophic_cardiac_calcinosis | 1.35879116 |
| 51 | MP0003866_abnormal_defecation | 1.35860204 |
| 52 | MP0005451_abnormal_body_composition | 1.35397488 |
| 53 | MP0002429_abnormal_blood_cell | 1.34452581 |
| 54 | MP0002722_abnormal_immune_system | 1.33365719 |
| 55 | MP0005167_abnormal_blood-brain_barrier | 1.31464984 |
| 56 | MP0010155_abnormal_intestine_physiology | 1.29899667 |
| 57 | MP0009764_decreased_sensitivity_to | 1.29316662 |
| 58 | MP0002796_impaired_skin_barrier | 1.29293248 |
| 59 | MP0000689_abnormal_spleen_morphology | 1.26089462 |
| 60 | MP0003191_abnormal_cellular_cholesterol | 1.26017558 |
| 61 | MP0005058_abnormal_lysosome_morphology | 1.25060138 |
| 62 | MP0005671_abnormal_response_to | 1.23338377 |
| 63 | MP0002998_abnormal_bone_remodeling | 1.20717372 |
| 64 | MP0004510_myositis | 1.20591793 |
| 65 | MP0005076_abnormal_cell_differentiation | 1.19942529 |
| 66 | MP0001873_stomach_inflammation | 1.19835728 |
| 67 | MP0004947_skin_inflammation | 1.19029602 |
| 68 | MP0005390_skeleton_phenotype | 1.18824834 |
| 69 | MP0001663_abnormal_digestive_system | 1.16505628 |
| 70 | MP0008469_abnormal_protein_level | 1.13512589 |
| 71 | MP0003111_abnormal_nucleus_morphology | 1.12299472 |
| 72 | MP0005310_abnormal_salivary_gland | 1.12102767 |
| 73 | MP0001958_emphysema | 1.11567458 |
| 74 | MP0002166_altered_tumor_susceptibility | 1.10520608 |
| 75 | MP0006054_spinal_hemorrhage | 1.10020028 |
| 76 | MP0003186_abnormal_redox_activity | 1.07744427 |
| 77 | MP0002928_abnormal_bile_duct | 1.05523385 |
| 78 | MP0003690_abnormal_glial_cell | 1.05019552 |
| 79 | MP0001986_abnormal_taste_sensitivity | 1.02524918 |
| 80 | MP0002933_joint_inflammation | 1.00912586 |
| 81 | MP0005164_abnormal_response_to | 1.00130473 |
| 82 | MP0010094_abnormal_chromosome_stability | 0.98391431 |
| 83 | MP0005174_abnormal_tail_pigmentation | 0.97630813 |
| 84 | MP0000490_abnormal_crypts_of | 0.95250625 |
| 85 | MP0003448_altered_tumor_morphology | 0.93725623 |
| 86 | MP0010234_abnormal_vibrissa_follicle | 0.93152474 |
| 87 | MP0004782_abnormal_surfactant_physiolog | 0.90212277 |
| 88 | MP0010307_abnormal_tumor_latency | 0.90209314 |
| 89 | MP0003077_abnormal_cell_cycle | 0.89940037 |
| 90 | MP0002138_abnormal_hepatobiliary_system | 0.89524918 |
| 91 | MP0005083_abnormal_biliary_tract | 0.89263014 |
| 92 | MP0008004_abnormal_stomach_pH | 0.89211045 |
| 93 | MP0002277_abnormal_respiratory_mucosa | 0.86641065 |
| 94 | MP0003453_abnormal_keratinocyte_physiol | 0.86279066 |
| 95 | MP0000703_abnormal_thymus_morphology | 0.84869954 |
| 96 | MP0002133_abnormal_respiratory_system | 0.84308547 |
| 97 | MP0005388_respiratory_system_phenotype | 0.84308547 |
| 98 | MP0004264_abnormal_extraembryonic_tissu | 0.83747174 |
| 99 | MP0003828_pulmonary_edema | 0.80596643 |
| 100 | MP0002877_abnormal_melanocyte_morpholog | 0.77890193 |
| 101 | MP0005377_hearing/vestibular/ear_phenot | 0.77708664 |
| 102 | MP0003878_abnormal_ear_physiology | 0.77708664 |
| 103 | MP0002006_tumorigenesis | 0.74018613 |
| 104 | MP0003221_abnormal_cardiomyocyte_apopto | 0.72388236 |
| 105 | MP0009763_increased_sensitivity_to | 0.71713643 |
| 106 | MP0005381_digestive/alimentary_phenotyp | 0.70860822 |
| 107 | MP0002019_abnormal_tumor_incidence | 0.70589481 |
| 108 | MP0009931_abnormal_skin_appearance | 0.69117732 |
| 109 | MP0003795_abnormal_bone_structure | 0.67584326 |
| 110 | MP0005166_decreased_susceptibility_to | 0.67244688 |
| 111 | MP0008057_abnormal_DNA_replication | 0.66790146 |
| 112 | MP0005075_abnormal_melanosome_morpholog | 0.65987737 |
| 113 | MP0009765_abnormal_xenobiotic_induced | 0.65882829 |
| 114 | MP0004957_abnormal_blastocyst_morpholog | 0.65801877 |
| 115 | MP0000015_abnormal_ear_pigmentation | 0.65099771 |
| 116 | MP0002282_abnormal_trachea_morphology | 0.63991864 |
| 117 | MP0002089_abnormal_postnatal_growth/wei | 0.62244433 |
| 118 | MP0001764_abnormal_homeostasis | 0.61502620 |
| 119 | MP0000579_abnormal_nail_morphology | 0.61482462 |
| 120 | MP0005319_abnormal_enzyme/_coenzyme | 0.61470762 |
| 121 | MP0000249_abnormal_blood_vessel | 0.61461988 |
| 122 | MP0002060_abnormal_skin_morphology | 0.61340871 |
| 123 | MP0003045_fibrosis | 0.60894775 |
| 124 | MP0008874_decreased_physiological_sensi | 0.60658324 |
| 125 | MP0000920_abnormal_myelination | 0.59591551 |
| 126 | MP0003806_abnormal_nucleotide_metabolis | 0.59490408 |
| 127 | MP0001216_abnormal_epidermal_layer | 0.59395661 |
| 128 | MP0000604_amyloidosis | 0.58121849 |
| 129 | MP0005409_darkened_coat_color | 0.56339334 |
| 130 | MP0005501_abnormal_skin_physiology | 0.52087972 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent gram-negative bacterial infections (HP:0005420) | 9.62420333 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 8.85260577 |
| 3 | Chronic obstructive pulmonary disease (HP:0006510) | 7.02499891 |
| 4 | Obstructive lung disease (HP:0006536) | 7.02499891 |
| 5 | Gingivitis (HP:0000230) | 6.24234339 |
| 6 | Mediastinal lymphadenopathy (HP:0100721) | 6.02825473 |
| 7 | Abnormality of macrophages (HP:0004311) | 5.76774567 |
| 8 | Recurrent skin infections (HP:0001581) | 5.02707762 |
| 9 | Cellulitis (HP:0100658) | 4.83370843 |
| 10 | Recurrent fungal infections (HP:0002841) | 4.72276148 |
| 11 | Urticaria (HP:0001025) | 4.70969105 |
| 12 | Optic neuritis (HP:0100653) | 4.65535219 |
| 13 | Retrobulbar optic neuritis (HP:0100654) | 4.65535219 |
| 14 | Papilledema (HP:0001085) | 4.30043628 |
| 15 | Stomatitis (HP:0010280) | 4.22422032 |
| 16 | Meningitis (HP:0001287) | 3.91157761 |
| 17 | Periodontitis (HP:0000704) | 3.19452406 |
| 18 | Episodic fever (HP:0001954) | 3.18084385 |
| 19 | Myositis (HP:0100614) | 3.05061381 |
| 20 | Recurrent pneumonia (HP:0006532) | 2.99228462 |
| 21 | Osteomyelitis (HP:0002754) | 2.97983335 |
| 22 | Anorexia (HP:0002039) | 2.89937300 |
| 23 | Sepsis (HP:0100806) | 2.85763899 |
| 24 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.78602567 |
| 25 | Amyloidosis (HP:0011034) | 2.76912407 |
| 26 | Peritonitis (HP:0002586) | 2.74914284 |
| 27 | Pulmonary infiltrates (HP:0002113) | 2.73803390 |
| 28 | Abnormal platelet volume (HP:0011876) | 2.72774059 |
| 29 | Cutaneous photosensitivity (HP:0000992) | 2.70010176 |
| 30 | Skin ulcer (HP:0200042) | 2.58866073 |
| 31 | Hypochromic anemia (HP:0001931) | 2.58482902 |
| 32 | Chromsome breakage (HP:0040012) | 2.55852950 |
| 33 | Petechiae (HP:0000967) | 2.53444629 |
| 34 | Arterial thrombosis (HP:0004420) | 2.53053424 |
| 35 | Inflammation of the large intestine (HP:0002037) | 2.52085347 |
| 36 | Premature loss of primary teeth (HP:0006323) | 2.51601198 |
| 37 | Spontaneous hematomas (HP:0007420) | 2.50456924 |
| 38 | Hypochromic microcytic anemia (HP:0004840) | 2.49256082 |
| 39 | Duplicated collecting system (HP:0000081) | 2.49195065 |
| 40 | Reticulocytopenia (HP:0001896) | 2.46011325 |
| 41 | Hypergammaglobulinemia (HP:0010702) | 2.45166166 |
| 42 | IgM deficiency (HP:0002850) | 2.42992961 |
| 43 | Gastrointestinal inflammation (HP:0004386) | 2.42660364 |
| 44 | Increased mean platelet volume (HP:0011877) | 2.40475727 |
| 45 | Difficulty running (HP:0009046) | 2.40221720 |
| 46 | Abnormality of nail color (HP:0100643) | 2.39430044 |
| 47 | Recurrent cutaneous fungal infections (HP:0011370) | 2.35362618 |
| 48 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.35362618 |
| 49 | Abnormality of DNA repair (HP:0003254) | 2.33773874 |
| 50 | Absent frontal sinuses (HP:0002688) | 2.29418366 |
| 51 | Epistaxis (HP:0000421) | 2.29361034 |
| 52 | Increased IgM level (HP:0003496) | 2.29097415 |
| 53 | Recurrent lower respiratory tract infections (HP:0002783) | 2.29080133 |
| 54 | Malnutrition (HP:0004395) | 2.25561859 |
| 55 | Eosinophilia (HP:0001880) | 2.24508488 |
| 56 | Leukocytosis (HP:0001974) | 2.24395946 |
| 57 | Recurrent viral infections (HP:0004429) | 2.22390074 |
| 58 | Cutaneous melanoma (HP:0012056) | 2.22322676 |
| 59 | Panhypogammaglobulinemia (HP:0003139) | 2.22308667 |
| 60 | Abnormality of T cell number (HP:0011839) | 2.21817461 |
| 61 | T lymphocytopenia (HP:0005403) | 2.21706654 |
| 62 | Hypermelanotic macule (HP:0001034) | 2.21523732 |
| 63 | Autoimmune thrombocytopenia (HP:0001973) | 2.21397870 |
| 64 | Increased serum ferritin (HP:0003281) | 2.21333091 |
| 65 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.20731749 |
| 66 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.20304594 |
| 67 | Thick nail (HP:0001805) | 2.16098078 |
| 68 | Colitis (HP:0002583) | 2.15695625 |
| 69 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.14432337 |
| 70 | Abnormality of T cells (HP:0002843) | 2.14231258 |
| 71 | Purpura (HP:0000979) | 2.13821137 |
| 72 | Hemoptysis (HP:0002105) | 2.08502940 |
| 73 | Keratoconjunctivitis sicca (HP:0001097) | 2.08055791 |
| 74 | Hepatosplenomegaly (HP:0001433) | 2.07400940 |
| 75 | Gingival bleeding (HP:0000225) | 2.07190509 |
| 76 | Abnormality of iron homeostasis (HP:0011031) | 2.06171715 |
| 77 | Abnormality of T cell physiology (HP:0011840) | 2.05030568 |
| 78 | Abnormality of glycolipid metabolism (HP:0010969) | 2.04450619 |
| 79 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.04450619 |
| 80 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.04450619 |
| 81 | Abnormality of the peritoneum (HP:0002585) | 2.04104069 |
| 82 | Abnormality of B cell number (HP:0010975) | 2.03310022 |
| 83 | B lymphocytopenia (HP:0010976) | 2.03310022 |
| 84 | Oral leukoplakia (HP:0002745) | 2.01647300 |
| 85 | Abnormality of the renal collecting system (HP:0004742) | 2.01298012 |
| 86 | Granulocytopenia (HP:0001913) | 2.00729282 |
| 87 | Eczematoid dermatitis (HP:0000976) | 10.8319396 |
| 88 | Recurrent abscess formation (HP:0002722) | 10.0116028 |
| 89 | Skin rash (HP:0000988) | 1.99466429 |
| 90 | Interstitial pulmonary disease (HP:0006530) | 1.97771856 |
| 91 | Orchitis (HP:0100796) | 1.96426904 |
| 92 | Prolonged bleeding time (HP:0003010) | 1.95757595 |
| 93 | Microcytic anemia (HP:0001935) | 1.95635622 |
| 94 | Vasculitis (HP:0002633) | 1.95633589 |
| 95 | Muscle fiber splitting (HP:0003555) | 1.95141797 |
| 96 | Pustule (HP:0200039) | 1.95058978 |
| 97 | Abnormal foot bone ossification (HP:0010675) | 1.94477145 |
| 98 | Vacuolated lymphocytes (HP:0001922) | 1.94300067 |
| 99 | Chest pain (HP:0100749) | 1.93169952 |
| 100 | Abnormality of the endocardium (HP:0004306) | 1.93147778 |
| 101 | Spinal cord lesions (HP:0100561) | 1.90228898 |
| 102 | Syringomyelia (HP:0003396) | 1.90228898 |
| 103 | Keratitis (HP:0000491) | 1.89884331 |
| 104 | Lymphopenia (HP:0001888) | 1.89229443 |
| 105 | Poikiloderma (HP:0001029) | 1.88800383 |
| 106 | Systemic lupus erythematosus (HP:0002725) | 1.88506208 |
| 107 | Acne (HP:0001061) | 1.88067625 |
| 108 | Metaphyseal cupping (HP:0003021) | 1.87913518 |
| 109 | Keratoconjunctivitis (HP:0001096) | 1.87875323 |
| 110 | Vertigo (HP:0002321) | 1.87486350 |
| 111 | Loss of speech (HP:0002371) | 1.86286777 |
| 112 | Entropion (HP:0000621) | 1.85311524 |
| 113 | Short 4th metacarpal (HP:0010044) | 1.84329623 |
| 114 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 1.84329623 |
| 115 | Pyloric stenosis (HP:0002021) | 1.82558915 |
| 116 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.82250357 |
| 117 | Glomerulopathy (HP:0100820) | 1.81455796 |
| 118 | Cheilitis (HP:0100825) | 1.81387114 |
| 119 | Disinhibition (HP:0000734) | 1.80096010 |
| 120 | Recurrent sinusitis (HP:0011108) | 1.78282353 |
| 121 | Increased IgE level (HP:0003212) | 1.77565918 |
| 122 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.72364041 |
| 123 | Tracheoesophageal fistula (HP:0002575) | 1.70035965 |
| 124 | Gangrene (HP:0100758) | 1.67414098 |
| 125 | Thickened calvaria (HP:0002684) | 1.67246069 |
| 126 | Spondylolisthesis (HP:0003302) | 1.66599482 |
| 127 | Increased cerebral lipofuscin (HP:0011813) | 1.66274458 |
| 128 | Delayed closure of the anterior fontanelle (HP:0001476) | 1.64661965 |
| 129 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.63719534 |
| 130 | Pulmonary embolism (HP:0002204) | 1.61432843 |
| 131 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.59858958 |
| 132 | Flared metaphyses (HP:0003015) | 1.58580969 |
| 133 | Abnormality of the pleura (HP:0002103) | 1.57567814 |
| 134 | Persistence of primary teeth (HP:0006335) | 1.56903899 |
| 135 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.56712615 |
| 136 | Papilloma (HP:0012740) | 1.56477589 |
| 137 | Verrucae (HP:0200043) | 1.56477589 |
| 138 | Myelodysplasia (HP:0002863) | 1.56348197 |
| 139 | Neutropenia (HP:0001875) | 1.56188887 |
| 140 | Gastrointestinal infarctions (HP:0005244) | 1.54860952 |
| 141 | Thoracic kyphosis (HP:0002942) | 1.52845023 |
| 142 | Abnormality of eosinophils (HP:0001879) | 1.52631615 |
| 143 | Long clavicles (HP:0000890) | 1.51734896 |
| 144 | Encephalitis (HP:0002383) | 1.49596342 |
| 145 | Menorrhagia (HP:0000132) | 1.49577242 |
| 146 | Ectopic kidney (HP:0000086) | 1.49565505 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRAK4 | 5.83578849 |
| 2 | TESK2 | 4.10296857 |
| 3 | EPHB1 | 3.37269809 |
| 4 | TESK1 | 3.18680605 |
| 5 | BLK | 2.99087939 |
| 6 | RIPK4 | 2.89446914 |
| 7 | BRSK2 | 2.65608846 |
| 8 | FES | 2.63227039 |
| 9 | GRK6 | 2.57217326 |
| 10 | CSK | 2.54239438 |
| 11 | WEE1 | 2.53312992 |
| 12 | MAP3K12 | 2.47810745 |
| 13 | TRPM7 | 2.45318657 |
| 14 | FGR | 2.44243575 |
| 15 | CLK1 | 2.39612098 |
| 16 | TNK2 | 2.33937169 |
| 17 | PRPF4B | 2.21504082 |
| 18 | BUB1 | 2.05467423 |
| 19 | MAP4K1 | 2.03792852 |
| 20 | ERBB3 | 1.91397970 |
| 21 | LIMK1 | 1.88245458 |
| 22 | ERN1 | 1.87263232 |
| 23 | MAP2K3 | 1.84376455 |
| 24 | STK10 | 1.76697310 |
| 25 | TTN | 1.73092116 |
| 26 | JAK3 | 1.71050603 |
| 27 | BRSK1 | 1.69245790 |
| 28 | BTK | 1.65347219 |
| 29 | PAK4 | 1.40822517 |
| 30 | IKBKE | 1.37688690 |
| 31 | HCK | 1.37537169 |
| 32 | SIK3 | 1.33816630 |
| 33 | MAP3K9 | 1.32227422 |
| 34 | CDC7 | 1.27241056 |
| 35 | NEK2 | 1.27144117 |
| 36 | TBK1 | 1.25675242 |
| 37 | MAP3K13 | 1.19520700 |
| 38 | STK4 | 1.18810360 |
| 39 | SYK | 1.15306216 |
| 40 | NEK1 | 1.14030144 |
| 41 | MAPK4 | 1.13977196 |
| 42 | ZAP70 | 1.13443296 |
| 43 | MARK2 | 1.07174113 |
| 44 | MAP2K4 | 1.03443254 |
| 45 | TEC | 1.02836820 |
| 46 | MAP3K2 | 1.02744050 |
| 47 | CAMKK2 | 1.01767105 |
| 48 | MAP2K6 | 1.01183441 |
| 49 | IRAK1 | 1.00400724 |
| 50 | LRRK2 | 0.98546257 |
| 51 | MARK3 | 0.98151487 |
| 52 | PRKD2 | 0.96966635 |
| 53 | TAOK2 | 0.95411776 |
| 54 | TRIB3 | 0.94283541 |
| 55 | MAP3K8 | 0.93497336 |
| 56 | TXK | 0.92198775 |
| 57 | IRAK2 | 0.86319703 |
| 58 | BMPR2 | 0.83213011 |
| 59 | IKBKB | 0.82868334 |
| 60 | MAP3K5 | 0.81342871 |
| 61 | CSF1R | 0.79501555 |
| 62 | PRKG2 | 0.79501222 |
| 63 | PIM1 | 0.77460697 |
| 64 | PTK6 | 0.74148002 |
| 65 | KDR | 0.73960241 |
| 66 | MAP3K11 | 0.73325797 |
| 67 | ALK | 0.71552817 |
| 68 | LYN | 0.70345760 |
| 69 | TGFBR2 | 0.68600705 |
| 70 | MAP3K7 | 0.67690219 |
| 71 | CDK19 | 0.67243112 |
| 72 | PRKCD | 0.67062263 |
| 73 | MAP3K14 | 0.65669640 |
| 74 | CCNB1 | 0.64162683 |
| 75 | RET | 0.64068499 |
| 76 | TAOK1 | 0.62402650 |
| 77 | RPS6KC1 | 0.62339067 |
| 78 | RPS6KL1 | 0.62339067 |
| 79 | RPS6KA6 | 0.61284796 |
| 80 | MAP3K3 | 0.59177048 |
| 81 | MAPK12 | 0.56532340 |
| 82 | CDK6 | 0.56218011 |
| 83 | EIF2AK3 | 0.55236771 |
| 84 | PTK2B | 0.55140942 |
| 85 | SMG1 | 0.53451137 |
| 86 | RPS6KA2 | 0.51727242 |
| 87 | CDC42BPA | 0.50254469 |
| 88 | MAPK7 | 0.49716403 |
| 89 | SGK3 | 0.49373701 |
| 90 | SIK1 | 0.48850726 |
| 91 | TLK1 | 0.47190555 |
| 92 | MYLK | 0.46208467 |
| 93 | ACVR1B | 0.45614264 |
| 94 | LCK | 0.45077297 |
| 95 | DYRK1B | 0.44955994 |
| 96 | PKN2 | 0.44893757 |
| 97 | PTK2 | 0.44490295 |
| 98 | RAF1 | 0.44066116 |
| 99 | FYN | 0.42968451 |
| 100 | HIPK2 | 0.41954131 |
| 101 | STK11 | 0.41842896 |
| 102 | TYK2 | 0.41554387 |
| 103 | TAOK3 | 0.40497411 |
| 104 | KSR1 | 0.40401288 |
| 105 | MAP3K1 | 0.39631639 |
| 106 | CAMKK1 | 0.39567760 |
| 107 | KSR2 | 0.39517945 |
| 108 | JAK2 | 0.39494036 |
| 109 | EPHA3 | 0.39047217 |
| 110 | MAPK11 | 0.38729233 |
| 111 | CDK4 | 0.38142143 |
| 112 | FGFR4 | 0.37863689 |
| 113 | MATK | 0.37782952 |
| 114 | DAPK2 | 0.35858395 |
| 115 | AURKB | 0.35702485 |
| 116 | MAPKAPK2 | 0.35348303 |
| 117 | VRK1 | 0.35241729 |
| 118 | PRKCQ | 0.34028494 |
| 119 | ITK | 0.33861803 |
| 120 | SIK2 | 0.33213888 |
| 121 | BMX | 0.32420776 |
| 122 | ILK | 0.31736057 |
| 123 | STK38 | 0.29627918 |
| 124 | PDPK1 | 0.28803153 |
| 125 | PRKCZ | 0.28412096 |
| 126 | PRKD1 | 0.27995665 |
| 127 | PDK1 | 0.27614633 |
| 128 | PLK1 | 0.27447814 |
| 129 | FGFR3 | 0.27302502 |
| 130 | KIT | 0.26549138 |
| 131 | PRKCH | 0.26347999 |
| 132 | GRK7 | 0.25825378 |
| 133 | SGK2 | 0.25599283 |
| 134 | MOS | 0.25531734 |
| 135 | MAP3K6 | 0.25118737 |
| 136 | CDK7 | 0.24846853 |
| 137 | EIF2AK2 | 0.24418469 |
| 138 | YES1 | 0.22450272 |
| 139 | DMPK | 0.20670622 |
| 140 | JAK1 | 0.19488254 |
| 141 | PIK3CG | 0.19468567 |
| 142 | ABL1 | 0.17509494 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 4.62026034 |
| 2 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 4.03205540 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.33257103 |
| 4 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 3.28425655 |
| 5 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.67656425 |
| 6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.48361325 |
| 7 | Tuberculosis_Homo sapiens_hsa05152 | 2.29527705 |
| 8 | Asthma_Homo sapiens_hsa05310 | 2.20295154 |
| 9 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.99880037 |
| 10 | Phagosome_Homo sapiens_hsa04145 | 1.96585388 |
| 11 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.95930167 |
| 12 | Shigellosis_Homo sapiens_hsa05131 | 1.92743123 |
| 13 | Pertussis_Homo sapiens_hsa05133 | 1.87987390 |
| 14 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.79598986 |
| 15 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.77679061 |
| 16 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.76117357 |
| 17 | Platelet activation_Homo sapiens_hsa04611 | 1.75093350 |
| 18 | Allograft rejection_Homo sapiens_hsa05330 | 1.73016945 |
| 19 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.66888052 |
| 20 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.60953453 |
| 21 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.60186971 |
| 22 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.59637218 |
| 23 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.51406204 |
| 24 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.48262480 |
| 25 | DNA replication_Homo sapiens_hsa03030 | 1.41446964 |
| 26 | Histidine metabolism_Homo sapiens_hsa00340 | 1.37764619 |
| 27 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.36820869 |
| 28 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.35171441 |
| 29 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.34719687 |
| 30 | Salmonella infection_Homo sapiens_hsa05132 | 1.33935890 |
| 31 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.26680648 |
| 32 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.23915244 |
| 33 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.23024300 |
| 34 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.21684179 |
| 35 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.17807857 |
| 36 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.15841598 |
| 37 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.14719664 |
| 38 | Cell cycle_Homo sapiens_hsa04110 | 1.13415430 |
| 39 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.12403913 |
| 40 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.07802471 |
| 41 | ABC transporters_Homo sapiens_hsa02010 | 1.07725203 |
| 42 | Legionellosis_Homo sapiens_hsa05134 | 1.06985581 |
| 43 | Other glycan degradation_Homo sapiens_hsa00511 | 1.03167960 |
| 44 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.02808238 |
| 45 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.99252748 |
| 46 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.98135348 |
| 47 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.96957437 |
| 48 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.94547254 |
| 49 | Hepatitis B_Homo sapiens_hsa05161 | 0.91656276 |
| 50 | Amoebiasis_Homo sapiens_hsa05146 | 0.89321489 |
| 51 | Viral myocarditis_Homo sapiens_hsa05416 | 0.88530804 |
| 52 | Malaria_Homo sapiens_hsa05144 | 0.87260854 |
| 53 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.86313357 |
| 54 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.85736774 |
| 55 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.84860409 |
| 56 | Apoptosis_Homo sapiens_hsa04210 | 0.82824775 |
| 57 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.81878547 |
| 58 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.81399569 |
| 59 | Insulin resistance_Homo sapiens_hsa04931 | 0.80841805 |
| 60 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.79909738 |
| 61 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.78941936 |
| 62 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.78716369 |
| 63 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.78040849 |
| 64 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.77584290 |
| 65 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.77409909 |
| 66 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.76198456 |
| 67 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.75308274 |
| 68 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.73608564 |
| 69 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.73251901 |
| 70 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.72525884 |
| 71 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.72383437 |
| 72 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.72281174 |
| 73 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.69691488 |
| 74 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.68402947 |
| 75 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.67654753 |
| 76 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.66885540 |
| 77 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.66787301 |
| 78 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.65934506 |
| 79 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.65318090 |
| 80 | Lysosome_Homo sapiens_hsa04142 | 0.65209786 |
| 81 | Bladder cancer_Homo sapiens_hsa05219 | 0.64163709 |
| 82 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.64023777 |
| 83 | Influenza A_Homo sapiens_hsa05164 | 0.62758111 |
| 84 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.62445547 |
| 85 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.61807716 |
| 86 | Salivary secretion_Homo sapiens_hsa04970 | 0.61547222 |
| 87 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.61293539 |
| 88 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.61088366 |
| 89 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.61064233 |
| 90 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.60254131 |
| 91 | Endocytosis_Homo sapiens_hsa04144 | 0.59896757 |
| 92 | Measles_Homo sapiens_hsa05162 | 0.58854415 |
| 93 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.57827750 |
| 94 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.57415784 |
| 95 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.56480116 |
| 96 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.56337596 |
| 97 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.55231819 |
| 98 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.53672480 |
| 99 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.53546848 |
| 100 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.53520055 |
| 101 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.53160637 |
| 102 | Endometrial cancer_Homo sapiens_hsa05213 | 0.52636363 |
| 103 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.52580810 |
| 104 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.52159974 |
| 105 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.51820981 |
| 106 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.51791674 |
| 107 | Galactose metabolism_Homo sapiens_hsa00052 | 0.51363164 |
| 108 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.51063984 |
| 109 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.49893661 |
| 110 | Hepatitis C_Homo sapiens_hsa05160 | 0.49302761 |
| 111 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.47895100 |
| 112 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.46177234 |
| 113 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.43482240 |
| 114 | Base excision repair_Homo sapiens_hsa03410 | 0.42240358 |
| 115 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.41917583 |
| 116 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.41820152 |
| 117 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.38057038 |
| 118 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.37672058 |
| 119 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.37579074 |
| 120 | Glioma_Homo sapiens_hsa05214 | 0.36241936 |
| 121 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.36053888 |
| 122 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.34883962 |
| 123 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.34151938 |
| 124 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.32333504 |
| 125 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.31699291 |
| 126 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.30556771 |
| 127 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.29462650 |
| 128 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.29250516 |

